# Donna H. Ryan

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/donna-h-ryan/

## Facts

| Field | Value |
| --- | --- |
| Citations | 37,859 |
| Field | Pharmacology and Obesity Treatment |
| h-index | 80 |
| i10-index | 229 |
| Last Known Institution | Pennington Biomedical Research Center |
| OpenAlex ID | https://openalex.org/A5088283488 |
| ORCID iD | 0000-0001-8374-2277 |
| Works | 390 |

## Researcher papers

Showing 12 of 13.

- [2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults](https://scholariq.org/papers/2013-aha-acc-tos-guideline-for-the-management-of-overweight-and-obesity-in/)
- [Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes](https://scholariq.org/papers/semaglutide-and-cardiovascular-outcomes-in-obesity-without-diabetes/)
- [2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults](https://scholariq.org/papers/2013-aha-acc-tos-guideline-for-the-management-of-overweight-and-obesity-in-2/)
- [Comparison of Weight-Loss Diets with Different Compositions of Fat, Protein, and Carbohydrates](https://scholariq.org/papers/comparison-of-weight-loss-diets-with-different-compositions-of-fat-protein-and/)
- [Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline](https://scholariq.org/papers/pharmacological-management-of-obesity-an-endocrine-society-clinical-practice/)
- [Joint international consensus statement for ending stigma of obesity](https://scholariq.org/papers/joint-international-consensus-statement-for-ending-stigma-of-obesity/)
- [Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial](https://scholariq.org/papers/effects-of-low-dose-controlled-release-phentermine-plus-topiramate-combination/)
- [Management of obesity](https://scholariq.org/papers/management-of-obesity/)
- [Weight Loss and Improvement in Comorbidity: Differences at 5%, 10%, 15%, and Over](https://scholariq.org/papers/weight-loss-and-improvement-in-comorbidity-differences-at-5-10-15-and-over/)
- [The Science of Obesity Management: An Endocrine Society Scientific Statement](https://scholariq.org/papers/the-science-of-obesity-management-an-endocrine-society-scientific-statement/)
- [Executive summary: Guidelines (2013) for the management of overweight and obesity in adults](https://scholariq.org/papers/executive-summary-guidelines-2013-for-the-management-of-overweight-and-obesity/)
- [Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial](https://scholariq.org/papers/long-term-weight-loss-effects-of-semaglutide-in-obesity-without-diabetes-in-the/)

## Researcher topics

- [Pharmacology and Obesity Treatment](https://scholariq.org/topics/pharmacology-and-obesity-treatment/)
- [Diet and metabolism studies](https://scholariq.org/topics/diet-and-metabolism-studies/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Bariatric Surgery and Outcomes](https://scholariq.org/topics/bariatric-surgery-and-outcomes/)
- [Obesity and Health Practices](https://scholariq.org/topics/obesity-and-health-practices/)

## Researcher university

- [Pennington Biomedical Research Center](https://scholariq.org/institutions/pennington-biomedical-research-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.